Cognitive performance in elderly women: Significance of the 19bp insertion/deletion polymorphism in the 5′ flank of the dopamine beta-hydroxylase gene, educational level, body fat measures, serum triglyceride, alcohol consumption and age

International Journal of Geriatric Psychiatry

Volumn 22, Issue 9, 2007, Pages 883-889

  Togsverd, Mads ^a   Werge, Thomas M ^a   Tankó, Laszlo ^b   Bagger, Yu Z ^b   Qin, George G ^b   Hansen, Thomas ^a   Christiansen, Claus ^b   Rasmussen, Henrik B ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

Author keywords

Body fat measures; Cognitive abilities; Dopamine beta hydroxylase; Genetic polymorphisms; Postmenopausal women

Indexed keywords

APOLIPOPROTEIN E4; DOPAMINE; DOPAMINE BETA MONOOXYGENASE; LIPID; NORADRENALIN; TRIACYLGLYCEROL;

ADULT; AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; BODY FAT; COGNITION; CONTROLLED STUDY; DATA ANALYSIS; DNA FLANKING REGION; DNA POLYMORPHISM; EDUCATION; ENVIRONMENTAL FACTOR; FEMALE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HUMAN; HUMAN EXPERIMENT; INTERVIEW; LIPID BLOOD LEVEL; POSTMENOPAUSE; REGRESSION ANALYSIS; SAMPLE SIZE; TRIACYLGLYCEROL BLOOD LEVEL;

5' UNTRANSLATED REGIONS; AGE FACTORS; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BODY COMPOSITION; COGNITION; CROSS-SECTIONAL STUDIES; DOPAMINE BETA-HYDROXYLASE; EDUCATIONAL STATUS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIPIDS; MENTAL STATUS SCHEDULE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; PSYCHOLOGICAL TESTS; REGRESSION ANALYSIS; RISK FACTORS; TRIGLYCERIDES;

EID: 34648828614     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1756     Document Type: Article

References (36)

1. Assmann G, Schulte H. 1992. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster study. Am J Cardiol 70: 733-737.
2. Bagger YZ, Tankó LB, Alexandersen P, et al. 2004. The implications of body fat mass and fat distribution for cognitive function in elderly women. Obes Res 12: 1519-1526.
3. Cattin L, Bordin P, Fonda M, et al. 1997. Factors associated with cognitive impairment among older Italian inpatients. Gruppo Italiano di Farmacovigilanza nell'Anziano (G.I.F.A.). J Am Geriatr Soc 45: 1324-1330.
4. Cleveland WS. 1979. Robust locally weighted regression and smoothing scatterplots. J Amer Statist Assoc 74: 829-836.
5. Collier TJ, Greene JG, Felten DL, et al. 2004. Reduced cortical noradrenergic neurotransmission is associated with increased neophobia and impaired spatial memory in aged rats. Neurobiol Aging 25: 209-221.
6. Combarros O, Alvarez-Arcaya A, Sanchez-Guerra M, et al. 2002. Candidate gene association studies in sporadic Alzheimer's disease. Dement Geriatr Cogn Disord 14: 41-54.
7. Cubells JF, Kranzler HR, McCance-Katz E, et al. 2000. A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry 5: 56-63.
8. Davidson Y, Gibbons L, Purandare N, et al. 2006. Apolipoprotein E epsilon4 allele frequency in vascular dementia. Dement Geriatr Cogn Disord 22: 15-19.
9. Doré S. 2005. Unique properties of polyphenol stilbenes in the brain: more than direct antioxidant actions; gene/protein regulatory activity. Neurosignals 14: 61-70.
10. Ducluzeau PH, Cousin P, Malvoisin E, et al. 2003. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. J Clin Endocrinol Metab 88: 3626-3631.
11. Gu Q. 2002. Neuromodulatory transmitter systems in the cortex and their role in cortical plasticity. Neuroscience 111: 815-835.
12. Huber PJ. 1967. The behavior of maximum likelihood estimates under nonstandard conditions. In Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability, Volume 1. University of California Press: Berkeley, CA; 221-223.
13. Inoue M, Suhara T, Sudo Y, et al. 2001. Age-related reduction of extrastriatal dopamine D2 receptor measured by PET. Life Sci 69: 1079-1084.
14. Katzman R, Brown T, Fuld P, et al. 1983. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry 140: 734-739.
15. Kauermann G, Carroll RJ. 2001. A note on the efficiency of the sandwich covariance matrix estimation. J Am Stat Assoc 96: 1387-1396.
16. Kirschner MA, Samojlik E, Drejka M, et al. 1990. Androgen-estrogen metabolism in women with upper body versus lower body obesity. J Clin Endocrinol Metab 70: 473-479.
17. Mukamal KJ, Kronmal RA, Mittleman MA, et al. 2003. Alcohol consumption and carotid atherosclerosis in older adults: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 23: 2252-2259.
18. Palmer AM. 1996. Neurochemical studies of Alzheimer's disease. Neurodegeneration 5: 381-391.
19. Payton A. 2006. Investigating cognitive genetics and its implications for the treatment of cognitive deficit. Genes Brain Behav 5(SI): 44-53.
20. Pinder RM, Sandler M. 2004. Alcohol, wine and mental health: focus on dementia and stroke. J Psychopharmacol 18: 449-456.
21. Qiu C, Winblad B, Fratiglioni L. 2005. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4: 487-499.
22. Rasmussen HB, Werge T. 2005. Genotyping of the 19-bp insertion/deletion polymorphism in the 5′ flank of beta-hydroxylase gene by dissociation analysis of allele-specific PCR products. Clin Chem Lab Med 43: 903-906.
23. Rasmussen HB, Bagger YZ, Tankó LB, et al. 2006. Cognitive impairment in elderly women: the relative contribution of selected genes, lifestyle factors and comorbidities. Neuropsychiatric Dis Treat 21: 227-233.
24. Rubinsztein DC, Easton DF. 1999. Apolipoprotein E genetic variation and Alzheimer's disease. A meta-analysis. Dement Geriatr Cogn Disord 10: 199-209.
25. Small BJ, Rosnick CB, Fratiglioni L, Backman L. 2004. Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 19: 592-600.
26. Stampfer MJ, Kang JH, Chen J, et al. 2005. Effects of moderate alcohol consumption on cognitive function in women. N Engl J Med 352: 245-253.
27. Stewart R, Russ C, Richards M, et al. 2001. Apolipoprotein E genotype, vascular risk and early cognitive impairment in an African Caribbean population. Dement Geriatr Cogn Dicord 12: 251-256.
28. Tankó LB, Bagger YZ, Alexandersen P, et al. 2003. Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 107: 1626-1631.
29. Tankó LB, Bruun JM, Alexandersen P, et al. 2004. Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesis. Circulation 110: 2246-2252.
30. Wakefield J. 2004. Non-linear regression modelling. In Methods and Models in Statistics. In Honor of Professor John Nelder, FRS, Adams N, Crowder M, Hand DJ, Stephens D (eds). Imperial College Press: London; 119-153.
31. Warming L, Ravn P, Nielsen T, Christiansen C. 2004. Safety and efficacy of drospirenone used in a continuous combination with 17beta-estradiol for prevention of postmenopausal osteoporosis. Climacteric 7: 103-111.
32. Warnick GR, Myers GL, Cooper GR, Rifai N. 2002. Impact of the third cholesterol report from the adult treatment panel of the national cholesterol education program on the clinical laboratory. Clin Chem 48: 11-17.
33. White H. 1980. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 48: 817-830.
34. Wilson RS, Mendes De Leon CF, Bennett DA, et al. 2004. Depressive symptoms and cognitive decline in a community population of older persons. J Neurol Neurosurg Psychiatry 75: 126-129.
35. Wood D, De Backer G, Faergeman O, et al. 1998. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 140: 199-270.
36. Zabetian CP, Anderson GM, Buxbaum SG, et al. 2001. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 68: 515-522.